Institution statistics

ENKAM PHARMACEUTICALS A/S - Denmark 

Ranking results:

Past rankings:
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2012 0 5.978.735 3.985.514 1
2011 0 3.757.318 0 1
2010 0 1.489.317 352.551 1
2008 0 2.970.372 330.041 1
2005 0 9.700.000 538.889 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Constancy:

Total number of partners:50

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 50

Frequent / Rare Partner Ratio: 0

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES3
RTD HORIZONTAL TOPICS2
SOCIAL AND ECONOMIC CONCERNS2
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2012-01-01Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders NEUROFGLparticipant5.978.7357
2011-03-01TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases TreatPolyQparticipant3.757.31816
2010-09-01A IAPP on the Role of NCAM in Stem Cell Differentiation STEMCAMparticipant1.489.3175
2008-02-01Synaptic mechanisms of memory loss: novel cell adhesion molecules as therapeutic targets MEMSTICKparticipant2.970.3729
2005-04-01From cell-cell recognition to memory formation. New strategies for the treatment of dysfunctional plasticity, learning and memory PROMEMORIAparticipant9.700.00018

Alias institution names:
  • ENKAM PHARMACEUTICALS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum